Blends, Growth Research

CJC-1295 (NO DAC) + Ipamorelin 5mg+5mg

Dual GHRH/GHS-R1a Agonist Blend

Price range: $63.90 through $543.15

Tested
Free Ship
Same Day
COA
Janoshik testing results
5mg + 5mg blend · Batch B003

Janoshik #209743 documents B003 identity and component amounts. Vanguard full-panel image previews are posted below for B003 purity, component mass, identity, endotoxin, sterility, and heavy metals; the Vanguard public verification link is posted.

Brief Description

Dual-peptide blend combining a GHRH analog (Mod GRF 1-29) with the ghrelin receptor agonist Ipamorelin. These act through complementary pathways — GHRH receptor and ghrelin receptor — producing synergistic pulsatile GH release in research models. The no-DAC form preserves natural GH pulsatility with a shorter duration of action. Research areas include combined-pathway GH secretion, body composition, and age-related somatopause investigation. For research use only — not for human consumption.

Compound Specifications
Purity
Verified
Research Library

Published scientific background, literature notes, and compound context for CJC-1295 (NO DAC) + Ipamorelin 5mg+5mg.

Read the CJC-1295 (NO DAC) + Ipamorelin 5mg+5mg research page →
Documentation & Lab Use
Form: Lyophilized research material
Documentation: Review the product label, batch records, and applicable laboratory SOPs before accessioning.
For research use only — not for human consumption
CJC-1295 (NO DAC) + Ipamorelin 5mg+5mg
CJC-1295 (NO DAC) + Ipamorelin 5mg+5mg
$63.90 $543.15Price range: $63.90 through $543.15

Additional information

Weight 0.94 oz
Pack Size

Single vial, 10-vial kit